Quantum Biopharma (QNTM) Notes Payables (2019 - 2026)

Quantum Biopharma has disclosed Notes Payables across 8 years of filings, most recently posting $300549.0 for Q1 2026.

• Notes Payables for Q1 2026 came in at $300549.0, down 72.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $300549.0 (down 72.37% YoY), and the FY2025 annual result was $1.3 million, up 110.1% from the prior year.
• Notes Payables came in at $300549.0 for Q1 2026 at Quantum Biopharma, down from $1.3 million in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $2.0 million in Q3 2025 to a low of $300549.0 in Q1 2022.
• The 5-year median for Notes Payables is $300549.0 (2022), against an average of $683187.2.
• Across the five-year window, Notes Payables jumped 557.23% in 2025 and sank 72.37% in 2026, its largest moves.
• Quantum Biopharma's Notes Payables stood at $300549.0 in 2022, then changed by 0.0% to $300549.0 in 2023, then surged by 105.97% to $619029.0 in 2024, then surged by 110.1% to $1.3 million in 2025, then slumped by 76.89% to $300549.0 in 2026.
• The last three Notes Payables figures came in at $300549.0 (Q1 2026), $1.3 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.